N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes
about
[Cardiac biomarkers in perioperative medicine : significance for noncardiac surgery patients].N-terminal pro-B-type natriuretic peptide as a diagnostic test for ventricular dysfunction in patients with coronary disease: data from the heart and soul studyPitfalls in cardiology: myocardial ischaemia in carbon monoxide poisoningQuick identification of acute chest pain patients study (QICS).NT-proBNP and circulating inflammation markers in prediction of a normal myocardial scintigraphy in patients with symptoms of coronary artery disease.Early discharge after primary percutaneous coronary intervention: the added value of N-terminal pro-brain natriuretic peptide to the Zwolle Risk Score.Assessment of cardiac risk before non-cardiac surgery: brain natriuretic peptide in 1590 patientsPostoperative B-type natriuretic Peptide levels associated with prolonged hospitalization in hypertensive patients after non-cardiac surgery.Clinical and laboratory diagnostics of cardiovascular disease: focus on natriuretic peptides and cardiac ischemia.Risk stratification of acute coronary syndrome patients. A multi-marker approach.Biomarkers in acute coronary syndromes and their role in diabetic patients.Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routineInterleukin-6 is the strongest predictor of 30-day mortality in patients with cardiogenic shock due to myocardial infarction.Plasma Levels of Soluble CD146 Reflect the Severity of Pulmonary Congestion Better Than Brain Natriuretic Peptide in Acute Coronary Syndrome.Atrial natriuretic peptide and related peptides.Association of serum carotenoid levels with N-terminal pro-brain-type natriuretic peptide: a cross-sectional study in Japan.Biomarkers in Acute Coronary Syndrome.A Comparison of Prognostic Value of the Levels of ProBNP and Troponin T in Patients with Acute Coronary Syndrome (ACS)Explicit risk in acute coronary syndrome managementN-terminal pro-B-type natriuretic peptide and inducible ischemia in the Heart and Soul Study.Updating the role of natriuretic peptide levels in cardiovascular disease.Mid-regional pro-adrenomedullin in acute heart failure: a better biomarker or just another biomarker?Natriuretic Peptide system and cardiovascular diseasePrognostic Value of Serial N-Terminal Pro-Brain Natriuretic Peptide Testing in Patients With Acute Myocardial Infarction.Assessing the clinical utility of biomarkers in medicine.B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide - Diagnostic role in stable coronary artery diseaseUtility of point-of-care testing of natriuretic peptides (brain natriuretic peptide and n-terminal pro-brain natriuretic peptide) in the emergency department.The IGF-1 receptor as a therapeutic target to improve endothelial progenitor cell function.Dynamic changes in N-terminal pro-brain natriuretic peptide in acute coronary syndromes treated with percutaneous coronary intervention: a marker of ischemic burden, reperfusion and outcome.Short-term residential cardiac rehabilitation reduces B-type natriuretic peptide.Cardiac biomarkers and survival in haemodialysis patients.Does admission NT-proBNP increase the prognostic accuracy of GRACE risk score in the prediction of short-term mortality after acute coronary syndromes?NT-ProBNP serum levels reflect severity and extent of ischemia in patients admitted with non-ST-elevation acute coronary syndrome.N-Terminal Pro-Brain Natriuretic Peptide Level is Associated With Severity and Complexity of Coronary Atherosclerosis in Patients With Acute Coronary Syndrome.N-terminal pro-brain natriuretic peptide could be a marker of subclinical atherosclerosis in patients with type 2 diabetes.N-terminal pro-B-type natriuretic peptide complements the GRACE risk score in predicting early and late mortality following acute coronary syndrome.Association between N-terminal pro-brain natriuretic peptide levels and contrast-induced nephropathy in patients undergoing percutaneous coronary intervention for acute coronary syndrome.Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction.N-terminal pro-B-type natriuretic peptide is associated with severity of the coronary lesions in unstable angina patients with preserved left ventricular function.Risk prediction in acute coronary syndrome from serial in-hospital measurements of N-terminal pro-B-type natriuretic peptide.
P2860
Q30318331-7CB9756D-B9AC-40A5-B9C3-B1F309F6F5A9Q31105305-C751C5EC-674B-4AED-B16B-2A5FA7F7916CQ33165317-0D478DCD-3420-4CA5-9A38-82C0F9C474FDQ33467558-CF7A2712-3DD7-4489-8C2A-3AF7D4966F45Q33769784-91B049D5-0D55-4D90-BEA4-74F2244E191FQ35114904-4E2CB274-681D-40E1-AA6C-48EEA438557DQ35772595-494C55F0-B77F-4F53-BA6C-8CC4CE294DA5Q36223062-C5B41163-A772-4798-88F7-E3A6CD21649EQ36236490-0165E34D-BC1D-41A5-A41F-EA8A29E845F8Q36236495-AB17CA62-C0CC-487B-9E1C-969DD7A03443Q36333917-5803EB59-4797-402E-AF96-A29CE44927CAQ36477929-AD46A9E3-243C-4ADA-9742-BA6209947C06Q36634008-66C25452-5B93-4178-947F-BB8740B297EAQ36864301-4C5372B2-0EBF-4EE8-828E-F16B3C07BCD6Q36896608-DBF02C38-E16F-4192-80CF-03CAD7DF0F24Q36978811-C803EB1F-6D9C-4AFD-81B4-0D2FEBBF364BQ37207294-B36FC681-DB81-4942-8EF0-300CD8DAB4F1Q37279802-B0E122B2-7D7A-4B13-8096-57BBD3A455E2Q37453028-880AF703-87AA-4A15-9E5E-FF2A9C921384Q37465179-1BEEA434-271D-4C2D-BCCA-B73F8CC0778DQ37959158-A40692A2-EE76-4220-99CF-8BA58366A841Q38021707-C5EA7622-2BF0-4A33-9BC6-B2FE8B2977DEQ39821577-655F2891-3A20-48DB-B4BF-6F9E8DB7B107Q40165610-FE79EB6D-4377-4F92-BE06-C35C5D45AA49Q40169397-5134A4C9-0747-4816-83F6-58715424DEFCQ42121470-6D535F2B-199F-4DC5-8616-34C6A9F22E0CQ42563345-ED9FA5C1-70AC-40C2-878A-6ED91047D91CQ43090694-7BD25E15-A71A-441A-8C98-06B20A66ADF1Q44792502-AD39B36B-4430-4488-9A7D-584DFE38AA5BQ45983590-C73E9259-5283-46F1-BA45-B17FB52AABEDQ48187379-EBE84C5D-18C9-4396-AF6A-9354250A19A5Q48463087-4DA043EA-ECED-44A6-AD40-53307C723D80Q48525307-E4BAD606-1B89-41C0-BFA5-0B3DA5AF0945Q48681415-3D794D1C-33E4-4CB2-A9FD-9135BAFFC620Q48718403-00C04EB9-233A-46CF-BDFB-53D6D2950997Q48787347-8D82F5E6-B56C-4FD6-931A-E1CE27B68A36Q48787719-214063DE-75E0-4882-9CF1-2CF8896223AFQ48788412-09107053-6B31-4B09-9195-786FC5421EF9Q48793828-7AE30290-8999-4291-8F78-CDC835133FB9Q49111539-D684F65D-ACE6-4EAF-9737-02684EAE62DB
P2860
N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes
description
2004 nî lūn-bûn
@nan
2004 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
N-terminal pro-B-type natriure ...... with acute coronary syndromes
@ast
N-terminal pro-B-type natriure ...... with acute coronary syndromes
@en
N-terminal pro-B-type natriure ...... with acute coronary syndromes
@nl
type
label
N-terminal pro-B-type natriure ...... with acute coronary syndromes
@ast
N-terminal pro-B-type natriure ...... with acute coronary syndromes
@en
N-terminal pro-B-type natriure ...... with acute coronary syndromes
@nl
prefLabel
N-terminal pro-B-type natriure ...... with acute coronary syndromes
@ast
N-terminal pro-B-type natriure ...... with acute coronary syndromes
@en
N-terminal pro-B-type natriure ...... with acute coronary syndromes
@nl
P2093
P3181
P1433
P1476
N-terminal pro-B-type natriure ...... with acute coronary syndromes
@en
P2093
Christopher Heeschen
Harvey D White
Nicte-Ha Lantelme
Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Investigators
Veselin Mitrovic
P304
P3181
P356
10.1161/01.CIR.0000147611.92021.2B
P407
P577
2004-11-08T00:00:00Z